Kertus

Activities: Design & Build Personal Protection Ingredients

Trending Articles

  1. The US FDA bans colour additive Red No. 3 from use in oral solid dosage forms Ingestible drug manufacturers will have until January 18, 2028 to reformulate their products, as Red No. 3 has been linked to cancer in male rats
  2. Touchlight becomes the first synthetic DNA API manufacturer to receive GMP certification The CDMO's Hampton, UK facility has received GMP certification to produce investigational APIs and critical starting materials for DNA vaccines and non-viral gene therapies
  3. Navin Molecular constructs a new R&D facility in Dewas, India The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity
  4. At MD&M West, TekniPlex Healthcare to emphasise turnkey capabilities for class III implantables and delivery systems Concept-to-commercialisation services include precision, tight-tolerance metalworking expertise and injection moulding solutions; company also will display bio-based PVC...
  5. TheHill and IMed Consultancy team up for digital health start-ups TheHill enlists IMed Consultancy for regulatory advice to start-ups in flagship NHS Market Access Accelerator Programme

Upcoming event

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France See all